Clearance Summary
BICARBOLYTE HEMO-DIAL received FDA 510(k) clearance under submission number K833896, sponsored by Edlaw Pharmaceuticals, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 1984-01-03.
- Submission: K833896
- Applicant / Sponsor: Edlaw Pharmaceuticals, Inc.
- Clearance pathway: Traditional
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.5820
- Decision date: 1984-01-03
Classification & Regulation
This clearance is catalogued under FDA product code KOC and 21 CFR 876.5820, within the Gastroenterology, Urology review panel as a Class II device.